Conformational properties of deltorphin: New features of the δ-opioid receptor  by Temussi, P.A. et al.
Volume 241, number 2, 283-288 FEB 07041 April 1989 
Conformational properties of deltorphin: new features of the 
S-opioid receptor 
P.A. Temussi*, D. Picone*, T. Tancred?, R. Tomatis, S. Salvadori, M. Marastoni and G. Balboni 
*Dipartimento di Chimica, University of Naples, via Mezzocannone 4,80134 Napoli, +ICMIB de1 CNR, Arco Felice, 
Napoli and Dipartimento di Scienze Farmaceutiche, University of Ferrara, via Scandiana 21, Ferrara. Italy 
Received 8 February 1989 
Deltorphin is an opioid peptide with the sequence H-Tyr-D-Met-Phe-His-Leu-Met-Asp-NH,, recently isolated from the 
skin of Phyllomedusa uvagei. Its enormous electivity towards the &opioid receptor and the similarity of the N-terminal 
part of the sequence with that of dermorphin (H-Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH,), a p selective peptide isolated 
from the same natural source, prompted a comparative conformational study. A ‘H-NMR study in two different solvent 
systems howed that the conformational preferences of the N-terminal sequences of the two peptides are similar. The 
different selectivities towards opioid receptors have been interpreted in terms of charge effects. Besides a general trend 
consistent with the role of the membrane in the preselection of the peptides, the present study demonstrates the crucial 
role played by charged residues in the interaction inside the receptors. 
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1. INTRODUCTION 
Selectivity of opiates towards the different recep- 
tor sites (x,&) is believed to be of key importance 
for separating analgesy from several unwanted 
side-effects. The recent discovery of deltorphin 
[ 1,2], new 
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Table 1 
April 1989 
Opioid activity of deltorphin, dermorphin and related fragments in guinea pig ileum (GPI), mouse vas deferens (MVD) and 
radioreceptoral assays expressed as ICso (nM) 
Peptides GPI MVD GPI/MVD [‘HIDADLE 
Tyr-D-Met-Phe-His-Leu-Met-Asp-NHza 2460 1.09 2.3 x10’ - 
Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2 ’ 1.07 23.16 0.05 
Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2 b 3.3 29 0.11 
Tyr-D-Met-Phe-Gly-Tyr-Pro-Ser-NH2 b 120 424 0.28 
Tyr-D-Ala-Phe-Gly-NH2 c - 818.1 
Tyr-D-Met-Phe-Gly-NH2 c - 467.0 
[‘HIDAGO [‘H]DAGG/[‘H]DADLE 
36.7 0.04 
9.1 0.02 
a 121 
b I41 
c PI 
part 6 or ,u specificity to opioid peptides, especially 
in comparison with peptides of the dermorphin 
family, whose message domain (Tyr-D-Ala-Phe), 
very similar to that of deltorphin (Tyr-D-Met-Phe), 
is generally considered responsible for their p selec- 
tivity. Table 1 shows that dermorphin has a relative 
p/S activity (measured as the ratio of the ICSO 
values found in the MVD and GPI tests) ranging 
from 9 to 20, whereas deltorphin has a relative S/p 
activity (measured as the reciprocal of the ratio 
used for dermorphin, i.e. as the ratio of the ICJO 
values found in the GPI and MVD tests) of 
2.3 x 103. 
We have already shown that peptides with Tyr- 
D-Ala-Phe as their N-terminal sequence can be 
good p- and/or S-opioids, with the only difference 
that 6 agonists have larger hydrophobic side chains 
in the C-terminal residues [6-S]. Substitution of D- 
Ala’ with D-Met’ cannot possibly be responsible 
for a selectivity reversal since there are many syn- 
thetic [D-Met2]analogues of dermorphin that 
possess high p specificity (table 1). However, 
before drawing conclusions on the influence (on 
,JfI selectivity) of sequential effects, it is essential 
to investigate the conformational preferences of 
deltorphin, in particular with respect to dermor- 
phin [6,10,11], since both peptides have con- 
siderable flexibility [9]. 
Here we present a preliminary conformational 
analysis of deltorphin, based on a proton NMR 
study in DMSOda and in the DMSO&H2O/D20 
cryoprotective mixture [12]. The similarity of the 
conformational preferences of dermorphin and 
deltorphin allows an interpretation of thep/d selec- 
tivity of deltorphin on the basis of a specific se- 
quential effect. 
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2. MATERIALS AND METHODS 
Deltorphin was synthesized by classical solution methods and 
purified by means of silica gel column chromatography, eluted 
with ethyl acetate/pyridine/acetic a id/water (60 : 20 : 6 : 11) and 
reverse-phase HPLC on Cis, eluted with a linear gradient of 
acetonitrile in water containing 0.1% trifluoroacetic acid. The 
final heptapeptide, m.p. 162-164°C. [cY]~ -9.2 (c 1.0, 
methanol), crystallized by methanol/diethyl ether, was isolated 
as ditrifluoroacetate. 
All spectra were run at 400 MHz on a Bruker AM-400 spec- 
trometer equipped with an Aspect 3000 computer and a variable 
temperature unit. Samples for NMR measurements were 6 mM, 
both in neat 99.98% DMSGd6 (Aldrich, Milwaukee, WI), or in 
a 80 : 10: 10 (v/v) DMSG.&H2G/DzG cryoprotective mixture. 
All chemical shifts refer to internal tetramethylsilane. Phase- 
sensitive DQF-COSY [13], NOESY [14] and HOHAHA [15] 
spectra were run at 300 K and at 280 K, for the DMSO and the 
cryoprotective mixture solutions, respectively. NOESY spectra 
were acquired using a 300 ms mixing time, with 8% random 
variation in order to minimize scalar and zero quantum con- 
tributions. Water suppression has been performed by preir- 
radiation of the water signal in the gated mode during the recy- 
cle and the mixing time. HOHAHA spectra were acquired in the 
low power transmitter mode; the 90” flip angle in this condition 
was 70 cs. The total mixing time was 45 ms. 
3. RESULTS AND DISCUSSION 
Full proton assignments to residue types, in the 
two solvent systems, were achieved by means of 
phase-sensitive DQF-COSY and HOHAHA 2D 
spectroscopy techniques. Sequential and side-chain 
assignments, based mainly on NOESY ex- 
periments, were deemed essential even for a 
preliminary study, since we wanted to compare the 
chemical shift of the ,&protons of D-Met’ to that 
of D-Ala’ in dermorphin. Accordingly it is 
necessary to assign unambiguously all side-chain 
resonances of both D-Met’ and L-Met6 residues 
before drawing conclusions on the conformation 
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of the peptide. Fig.1 shows the 1D spectrum of 
deltorphin in DMSOd,j, with the assignments la- 
beled by standard one-letter codes for amino acid 
residues. 
Table 2 summarizes relevant spectral parameters 
for the labile backbone protons in the two solvent 
systems employed; most of the chemical shifts have 
values consistent with standard literature values 
[16]. None of the temperature coefficients are close 
enough to zero to indicate conclusively the 
presence of stable hydrogen bonds [17], but it may 
be noted that they are spread over a rather large 
range. Accordingly, it is possible that the smaller 
values reflect the contribution of folded con- 
formers in equilibrium with more extended confor- 
mations. Fig.2 shows a portion of the phase- 
sensitive NOESY spectrum of deltorphin in the 
cryoprotective mixture at 280 K. This spectrum, 
D am 
‘1 
,6 
Fa Ma 
Ha 1-a 
C2H “a 
Fig.l.400 MHz proton spectrum of deltorphin in DMSOd6 (3 mg/0.5 ml) at 300 K. All resonances are labeled by the standard one-letter 
codes for amino acid residues; lower case letter stands for D-residue. 
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Table 2 
Chemical shifts (6 at 295 K) and temperature coefficients 
(AHAT) of amide protons of deltorphin 
DMSO DMSO/H20/D20 
(80: 10: 10) 
Tyr ’ 
Met2 
Phe’ 
His4 
Leu’ 
Met6 
Asp’ 
6 AS/AT 6 AS/A T 
8.47 -3.7 a.45 -4.0 
8.41 - 5.3 8.39 -5.9 
8.52 -7.0 8.44 -7.0 
8.11 - 4.0 8.21 -4.9 
8.28 -4.8 8.34 -6.8 
8.02 -4.8 8.08 -5.3 
with respect o the analogous one in neat DMSO,j,j 
at room temperature, is characterized by the 
presence of a much larger number of NOES. 
All sequential NH-C,H and many long range in- 
trachain NOES are visible. These results indicate 
that the mixture of conformations present in solu- 
tion is not made up solely of random extended 
chains. 
The chemical shifts of the side-chain protons of 
D-Met2 proved diagnostically valuable. In both 
solvent systems, all side-chain protons of D-Met’ 
have unusually high-field chemical shifts, in par- 
ticular the ,&CH2 protons (1.30-1.37 ppm in 
DMSO at 300 K). It had already been noticed in 
dermorphin and its fragments [lo] that the 
chemical shift of the methyl group of D-Ala’ is 
unusually low with respect to the standard value 
for alanine [16] and that the high-field shift is 
paralleled by a high /I activity. Thus, although 
some parameters, related to the backbone protons, 
point to a disordered state, it is possible that most 
conformations present in solution have a similar 
arrangement of residues 2 and 3, that represents a
local relative energy minimum. It seems ignificant 
that H-Tyr-D-Ala-Phe-Gly-NH2, in the type II ’ ,& 
turn conformation consistent with a model of p 
receptor [6] based on rigid opiates, has the methyl 
group of D-Ala’ and the ring of Phe3 at a short 
enough distance to induce a large diamagnetic shift 
in the resonance of the methyl group of D-Ala. 
Thus, also in the case of deltorphin, it seems 
reasonable to assume that the relative arrangement 
of residues 2 and 3 is similar to that present in the 
&turn that fits the model receptor we proposed for 
p and S peptides [6]. 
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Our solution study in polar solvents confirms 
that the main conformational features of k- and 6- 
opioids are similar, at least in the N-terminal 
region. In fact, it can be said that the sequence 
Tyri-D-Xxx’-Phe’, long believed to be character- 
istic of p-opioids only, is an ideal feature of both p- 
and S-opioid peptides. The cause of the reversal of 
selectivity in going from the sequence of dermor- 
phin to that of deltorphin must be sought in the 
properties of residues 4 to 7. We propose that the 
key factor causing ,u to 6 reversal is charge in the 
message domain. 
The importance of charges in orienting the 
specificity of opioid peptides has already been 
pointed out by Schwyzer [ 18-201, in the framework 
of his theory on the catalytic role of membranes for 
peptide-receptor interactions [21]. In particular, he 
has proposed that ‘.. . selection for 6 receptors is 
reduced by the effective positive charge’. Thus, it is 
understandable that deamidation of dermorphin 
causes a decrease in p activity, whereas amidation 
of the terminal carboxyl group of enkephalins 
decreases the S activity in favor of a slight increase 
of the/L activity. Also, the negative charge in the C- 
terminal part of deltorphin (Asp’) has a role similar 
to the C-terminal carboxyl group of enkephalins, 
and is consistent with the general requirements of 
Schwyzer’s theory. 
Acritical use of the membrane compartment 
concept [la] however has a serious drawback: 
specific receptor requirements may not be given 
due consideration. Thus, it is indeed very difficult 
to explain, solely on the basis of the membrane 
model, why introduction of the positive charge of 
His in the fourth residue, i.e. at the border of the& 
turn required for recognition of /c and 6 peptides 
[6], instead of lowering the S selectivity, leads to the 
natural opioid peptide with the highest known 6 
specificity. These observations strongly favor a 
specific role of the receptor in the selection of p and 
6 agonists, in addition to the catalytic role of the 
membrane in their pre-selection. 
It seems fair to conclude that the picture of the 6 
receptor that emerges from the present work is 
similar to that proposed for the ,u receptor [6], with 
an important difference: the ability to tolerate 
charges outside the region that recognizes the ,&- 
turn of the N-terminal region of the peptides. This 
view receives further support by the recent 
discovery, in frog skin, of two new deltorphins 
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Fig.2. Part of the 400 MHz phase-sensitive NOESY spectrum of deltorphin in the cryoprotective mixture DMSG&water 80: 20, v/v, 
at 280 K. The mixing time was 300 ms, with 8% random variation. Zero filling of the 2 K x 256 W acquired matrix to 4 K x 1 K has 
been performed prior to transformation; Gaussian-type windows were applied in both dimensions. Standard one letter codes for amino 
acid residue labeling have been used, with lower case letters standing for D-residue. This portion of the spectrum shows the dipolar cor- 
relations from amide and aromatic protons to LY and side chain protons. 
(Melchiorri, P., personal communication) that 
display even higher S/F selectivity (deltorphin B: 
Tyr-D-Ala-Phe-Glu-Val-Val-Gly-NHz; deltorphin 
C: Tyr-D-Ala-Phe-Asp-Val-Val-Gly-NHZ). They 
have a message domain identical to that of dermor- 
phin and bear a negative charge in the fourth 
residue, showing that the sign of the charge in this 
position is inmaterial in determining rejection by 
the ~1 site. 
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